Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
about
Effect of octreotide on gall stone prevalence and gall bladder motility in acromegalyGall stones and gall bladder motility.Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.Somatostatin and its analogs in the short bowel syndrome.Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly.Medical therapy of acromegalySomatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients.Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors.Octreotide LAR: safety and tolerability issues.Octreotide long-acting repeatable for acromegaly.Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital.Emerging drugs for acromegaly.Current and future medical treatments for patients with acromegaly.Continuous versus intermittent subcutaneous infusion of octreotide in the treatment of acromegaly.Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors.Sphincterotomy and the gall bladder--a slice of luck.Octreotide is not effective in the acute treatment of migraine.One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release.Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors.Prophylactic Cholecystectomy at Time of Surgery for Small Bowel Neuroendocrine Tumor Does Not Increase Postoperative Morbidity.Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
P2860
Q28378658-7FA31615-4C03-4379-8C55-AB4D463FB307Q34377137-FC865A0C-2606-4989-B833-D75BAE6DF58CQ35009459-54BA7FBB-673D-42A9-A3D4-C7F811D1074FQ35278712-64662E1F-EBCE-45F9-9E01-90030A5DC362Q35597307-645C6E68-755A-4E8D-AB88-947C8C11E429Q35895856-7C1C39C7-16A6-4934-9725-894D8CACC111Q37292997-B37F9BF6-EE16-4293-80BD-7AA149C695ACQ37483944-B1D1114B-86D4-4418-9DA3-F48A4E1A3937Q37649647-CDBBC44E-8780-4D5C-9AFF-C22B9DEA0EF5Q37990556-E061B385-F208-46FC-B526-1BA9C6489410Q38111630-78468983-3757-4F05-A7B4-6291E853890CQ38176659-7A92BDAA-9A22-4068-9E0D-E6B155016A0CQ38847622-26815AAC-1F36-45E0-8F59-64B915718CD8Q40526147-F59E2116-B0F9-48AA-BC56-04A5803527D1Q41345567-8E8BBA1C-2489-480C-B9BB-34D5A00CE234Q43226533-D89067A8-DF61-48EF-BFE3-A5EABEE5F721Q45192198-DE42D38D-76A0-444F-B511-98EAB1FE67F0Q46840350-488A1872-1545-4C2F-AA9E-AF0582703EB2Q47944297-8E94F054-DDD3-4B39-840E-B09DDCECC804Q50079508-825370F4-87D2-40B1-9F7B-2E70965FA65EQ53028031-5E8C63C5-FCD0-4A2A-865A-4701694C652B
P2860
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@ast
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@en
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@nl
type
label
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@ast
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@en
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@nl
prefLabel
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@ast
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@en
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@nl
P2093
P356
P1476
Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly
@en
P2093
D Dienemann
H J Quabbe
U Plöckinger
P304
P356
10.1210/JCEM-71-6-1658
P407
P577
1990-12-01T00:00:00Z